GO:0001222 transcription corepressor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001222 transcription corepressor binding describes the molecular function of a protein physically binding to a transcription corepressor, a non-DNA-binding protein that negatively regulates transcription through protein-protein interactions.
• Corepressor binding is a prerequisite for the assembly of repressive complexes that bridge DNA-bound transcription factors to the basal transcription machinery and to chromatin-modifying enzymes.
• Key corepressors include CtBP1/2, TBL1XR1, ETO, MORC2 and HUSH complex components, which recruit histone deacetylases, methyltransferases and chromatin compaction activities.
• Dysregulation of corepressor binding is linked to lymphoma, leukemia, neurodevelopmental disorders and memory-related synaptic plasticity defects.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect whether a candidate corepressor-binding interface is causally required for repression.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study transcription corepressor binding in disease-relevant contexts.
Description
Transcription corepressor binding (GO:0001222) is a molecular function that captures the physical interaction between a protein and a transcription corepressor. Corepressors are proteins that do not bind DNA directly; instead, they are recruited by DNA-bound transcription factors and mediate negative regulation of transcription through protein-protein interactions with the basal transcription machinery and chromatin-modifying enzymes. This function is central to gene silencing, developmental decisions and cellular responses to environmental cues. Researchers study GO:0001222 to understand how repressive complexes are assembled, how specificity is achieved, and how mutations in corepressor-binding interfaces contribute to disease. The term is distinct from DNA binding and from transcription factor activity because the corepressor itself lacks sequence-specific DNA-binding activity. Instead, binding to a corepressor enables a protein to act as a bridge or scaffold that recruits repressive enzymatic activities, such as histone deacetylases and histone methyltransferases, to target loci. In this article, we synthesize authoritative QuickGO annotation and verified PubMed literature to explain the mechanism, key genes, disease links and research methods for GO:0001222.
transcription corepressor binding At A Glance
| GO ID | GO:0001222 |
|---|---|
| GO term | transcription corepressor binding |
| Ontology | molecular_function |
| Synonym | RNA polymerase II transcription corepressor binding |
| Major function | Binding to a transcription corepressor to mediate negative regulation of transcription via protein-protein interactions |
| Definition source | QuickGO definition: binding to a transcription corepressor, a protein involved in negative regulation of transcription via protein-protein interactions with transcription factors and other proteins that negatively regulate transcription |
| DNA binding | Corepressors do not bind DNA directly; they mediate protein-protein interactions between repressing transcription factors and the basal transcription machinery |
| Representative corepressors | CtBP1/2, TBL1XR1, ETO, MORC2, HUSH complex components |
| Disease relevance | Lymphoma, leukemia, neurodevelopmental disorders and memory-related synaptic plasticity defects |
What Is GO:0001222?
In our own words, GO:0001222 transcription corepressor binding is the molecular function of selectively and non-covalently interacting with a transcription corepressor. A transcription corepressor is defined as a protein involved in negative regulation of transcription via protein-protein interactions with transcription factors and other proteins that negatively regulate transcription. Corepressors do not bind DNA directly; rather, they mediate protein-protein interactions between repressing transcription factors and the basal transcription machinery. This function is therefore a protein-binding activity that enables the formation of repressive transcription complexes, often leading to chromatin modification and reduced RNA polymerase II activity.
Why Is transcription corepressor binding Important in Cell Biology?
GO:0001222 is important because it defines a fundamental mechanism by which cells silence genes. Without corepressor binding, repressive transcription factors cannot efficiently recruit chromatin-modifying enzymes or block the basal transcription machinery, leading to inappropriate gene activation. This function is essential for normal development, differentiation and memory storage, and its dysregulation is implicated in cancer and neurological disorders. Understanding corepressor binding at the molecular level informs the design of targeted therapies that disrupt pathological repression complexes.
• Corepressor binding is required for the assembly of repressive complexes that silence developmental and oncogenic gene programs.
• Mutations in corepressor-binding proteins such as TBL1XR1 drive extranodal lymphoma by inducing a pro-tumorigenic memory fate.
• CtBP1/2 oligomerization and corepressor binding promote G9a-mediated transcriptional repression, linking metabolism to epigenetic silencing.
• The HUSH-MORC2 corepressor complex depends on corepressor binding to restrict repeats and maintain genome stability.
• Corepressor binding is critical for memory storage and synaptic plasticity, as shown by studies of transcriptional co-repressors in the brain.
• Dysregulated corepressor binding contributes to leukemia and solid tumors through aberrant recruitment of histone deacetylases and methyltransferases.
• Understanding corepressor binding enables the development of small-molecule inhibitors that block pathological protein-protein interactions.
• CRISPR-based models of corepressor-binding interfaces are essential for validating causal roles in disease.
• Corepressor binding is a key node in the transcription preinitiation process, influencing RNA polymerase II recruitment.
• Studying corepressor binding helps explain how DNA methylation and chromatin context govern sensitivity to repression.
Molecular Mechanism of transcription corepressor binding
Recruitment of corepressors by DNA-bound transcription factors
In simple terms: A DNA-bound protein grabs a corepressor to start shutting a gene off.
Transcription corepressors do not bind DNA directly; they are recruited to target loci through protein-protein interactions with DNA-bound transcription factors. This recruitment is the first step in negative regulation and determines which genes are silenced. For example, the ETO corepressor binds E proteins with multivalent interactions to facilitate dual repression controls targeting chromatin and the basal transcription machinery. Similarly, TBL1XR1 mutations alter recruitment of corepressor complexes in lymphoma.
Multivalent binding and complex assembly
In simple terms: Multiple weak contacts combine to make a stable repressive machine.
Corepressor binding often involves multivalent interactions that increase specificity and stability. The ETO corepressor uses multivalent binding to E proteins to coordinate repression of chromatin and the basal transcription machinery. CtBP1/2 oligomerization promotes G9a-mediated transcriptional repression, showing that higher-order assembly of corepressor-binding proteins is functionally important. NADH/NAD(+) binding and linked tetrameric assembly of CtBP1 and CtBP2 further illustrate how metabolic cofactors regulate corepressor complex formation.
Chromatin modification and basal transcription machinery targeting
In simple terms: The corepressor brings enzymes that chemically modify chromatin and block the transcription start site.
Once bound, corepressors recruit histone deacetylases, histone methyltransferases and other chromatin-modifying enzymes to establish a repressive chromatin state. The ETO corepressor facilitates dual repression controls targeting chromatin and the basal transcription machinery. The HUSH-MORC2 corepressor complex restricts repeats in a DNA methylation-dependent manner, linking corepressor binding to chromatin context. These activities ultimately reduce RNA polymerase II occupancy and transcription initiation.
Regulation by metabolic and signaling cues
In simple terms: The cell's metabolic state can tune how well corepressors bind and repress.
Corepressor binding is not constitutive; it can be regulated by metabolic cofactors and signaling. NADH/NAD(+) binding and linked tetrameric assembly of CtBP1 and CtBP2 demonstrate that redox state influences corepressor complex formation. Histone H3.3 phosphorylation amplifies stimulation-induced transcription, indicating that chromatin marks can oppose or modulate repression. DNA methylation governs the sensitivity of repeats to restriction by the HUSH-MORC2 corepressor, showing that epigenetic context regulates corepressor function.
Role in transcription preinitiation and memory storage
In simple terms: Corepressor binding affects the very first steps of transcription and even how memories are stored.
Corepressor binding influences transcription preinitiation by interfering with the assembly of the preinitiation complex. In the brain, transcriptional co-repressors are critical for memory storage, and their binding partners regulate synaptic plasticity. This dual role in basic transcription and higher-order brain function highlights the broad importance of GO:0001222.
Key Genes Involved in GO:0001222 transcription corepressor binding
The following genes encode proteins that bind transcription corepressors or are themselves corepressors, and they are frequently studied in the context of GO:0001222.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CTBP1 | Corepressor that binds transcription factors and recruits G9a | Oligomerization and NADH/NAD+ binding regulate repression; linked to cancer |
| CTBP2 | Paralog of CTBP1 with similar corepressor function | Tetrameric assembly and metabolic regulation; cancer and developmental roles |
| TBL1XR1 | Component of corepressor complexes; binds transcription factors | Mutations drive extranodal lymphoma via pro-tumorigenic memory fate |
| ETO (RUNX1T1) | Corepressor that binds E proteins multivalently | Dual repression of chromatin and basal transcription machinery |
| MORC2 | Part of HUSH corepressor complex | DNA methylation-dependent restriction of repeats |
| HUSH complex components | Corepressor complex that silences repeats | Genome stability and epigenetic silencing |
| G9a (EHMT2) | Histone methyltransferase recruited by corepressors | CtBP1/2-mediated repression |
| HDACs | Histone deacetylases recruited by corepressors | Chromatin repression and gene silencing |
| E proteins (TCF3, TCF12) | Transcription factors that bind ETO corepressor | Multivalent binding and dual repression |
| NCOR1 | Classical transcription corepressor | Negative regulation of transcription via protein-protein interactions |
| NCOR2 (SMRT) | Classical transcription corepressor | Recruits HDACs to repress transcription |
| SIN3A | Scaffold corepressor | Part of histone deacetylase complexes |
| KDM1A (LSD1) | Chromatin-modifying corepressor | Demethylates histones to repress transcription |
| H3.3 (H3F3A) | Histone variant whose phosphorylation amplifies transcription | Modulates stimulation-induced transcription and repression balance |
| REST | Transcription factor that recruits corepressors | Neuronal gene silencing and memory |
| CoREST | Corepressor that binds REST and HDACs | Neuronal gene regulation and memory storage |
How Is transcription corepressor binding Regulated?
Transcription corepressor binding is regulated at multiple levels. Metabolic cofactors such as NADH/NAD+ control the oligomeric state and binding activity of CtBP1/2, linking cellular redox status to repression. DNA methylation governs the sensitivity of repeats to restriction by the HUSH-MORC2 corepressor, showing that epigenetic marks regulate corepressor recruitment. Histone H3.3 phosphorylation amplifies stimulation-induced transcription, which can counteract repressive complexes. In the brain, transcriptional co-repressors and their binding partners are regulated during memory storage, indicating activity-dependent control. These examples illustrate that corepressor binding is dynamically tuned by metabolic, epigenetic and signaling inputs.
transcription corepressor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TBL1XR1 | Extranodal lymphoma | Knockout and point-mutation cell lines |
| CTBP1/2 | Cancer and transcriptional repression | Oligomerization mutants and overexpression models |
| ETO (RUNX1T1) | Leukemia | Knock-in of fusion protein and binding mutants |
| MORC2 | Repeat instability and epigenetic silencing | Knockout and DNA methylation perturbation |
| REST/CoREST | Memory disorders | Neuronal knockout and rescue models |
Lymphoma and leukemia
Mutations in TBL1XR1, a component of corepressor complexes, drive extranodal lymphoma by inducing a pro-tumorigenic memory fate. CtBP1/2 oligomerization promotes G9a-mediated transcriptional repression, and dysregulation of this axis is implicated in cancer. ETO corepressor binding to E proteins is relevant to leukemia-associated fusion proteins. These findings link GO:0001222 to hematological malignancies.
Neurodevelopmental and memory disorders
Transcriptional co-repressors and their binding partners are critical for memory storage and synaptic plasticity. Disruption of corepressor binding in neurons can impair learning and memory, suggesting relevance to neurodevelopmental and neurodegenerative conditions. REST and CoREST complexes, which depend on corepressor binding, regulate neuronal gene expression.
Genome instability and repeat-associated disease
The HUSH-MORC2 corepressor complex restricts repeats in a DNA methylation-dependent manner, and loss of this function can lead to genome instability. This links corepressor binding to repeat-associated diseases and epigenetic silencing defects.
From transcription corepressor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the corepressor-binding interface required for repression? | Point-mutation knock-in of binding-deficient alleles |
| Does loss of corepressor binding affect tumor growth? | Knockout cell lines and xenografts |
| How does oligomerization regulate corepressor function? | Tagged knock-in and oligomerization mutants |
| What genes are silenced by a specific corepressor? | Overexpression followed by RNA-seq |
| Does DNA methylation control corepressor recruitment? | Knockout of methylation machinery and rescue |
| How does corepressor binding affect memory? | Neuronal knockout and behavioral assays |
How to Study the transcription corepressor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of corepressor protein function | Phenotypic screening |
| Point-mutation knock-in | Effect of disrupting a specific binding interface | Causal validation |
| RNA-seq | Changes in gene expression | Identifying derepressed genes |
| Proteomics | Protein-protein interactions | Mapping corepressor complexes |
| ChIP-seq | Genome-wide binding of corepressors | Locus-specific recruitment |
| Live-cell imaging | Dynamic recruitment of corepressors | Real-time repression studies |
| Behavioral assays | Memory and synaptic plasticity | Neuronal corepressor function |
CRISPR knockout and point-mutation models
CRISPR knockout of corepressor genes or their binding partners can reveal loss-of-function phenotypes. Point mutations that disrupt specific binding interfaces are useful to separate corepressor binding from other functions. These models are essential for causal inference in disease contexts.
Transcriptomics and RNA-seq
RNA-seq after knockout or overexpression of corepressor-binding proteins identifies derepressed gene sets. This approach can reveal whether a candidate protein acts as a corepressor or opposes repression.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry can identify corepressor complexes and their binding partners. This is critical for defining the composition of repressive complexes.
Imaging and chromatin assays
Live-cell imaging and chromatin immunoprecipitation can measure recruitment of corepressors to specific loci. These methods link binding events to changes in chromatin state and transcription.
How CRISPR Can Be Used to Study GO:0001222 transcription corepressor binding
Knockout
CRISPR knockout of corepressor genes such as CTBP1/2, TBL1XR1 or MORC2 can abolish repression and reveal target gene derepression. Knockout models are foundational for linking GO:0001222 to disease phenotypes.
Point Mutation
Point mutations that disrupt specific corepressor-binding interfaces allow separation of binding from other activities. For example, mutating the ETO binding domain can test its role in dual repression.
Knock-in
Knock-in of tagged or mutant corepressors enables tracking of complex assembly and recruitment in live cells. This is useful for studying oligomerization and metabolic regulation.
Overexpression
Overexpression of corepressor-binding proteins can amplify repression and identify downstream silenced genes. This approach is often combined with RNA-seq to define corepressor-regulated transcriptomes.
How EDITGENE Supports transcription corepressor binding Research
Researchers studying transcription corepressor binding-related genes often need to determine whether a candidate gene is causally involved in repression, whether a specific binding interface is required, and how loss or gain of function affects disease-relevant phenotypes. EDITGENE provides the CRISPR cell models and screening services needed to answer these questions rigorously.
Contact EDITGENE today to design your custom CRISPR model for transcription corepressor binding research.
Frequently Asked Questions About transcription corepressor binding
What is transcription corepressor binding?
Transcription corepressor binding (GO:0001222) is the molecular function of binding to a transcription corepressor, a protein that negatively regulates transcription through protein-protein interactions without binding DNA directly.
What genes are involved in transcription corepressor binding?
Key genes include CTBP1, CTBP2, TBL1XR1, ETO (RUNX1T1), MORC2, NCOR1, NCOR2, SIN3A, KDM1A, REST and CoREST.
How does transcription corepressor binding repress transcription?
Corepressors are recruited by DNA-bound transcription factors and then recruit chromatin-modifying enzymes and block the basal transcription machinery.
What diseases are linked to transcription corepressor binding?
Dysregulation is linked to lymphoma, leukemia, neurodevelopmental and memory disorders, and repeat-associated genome instability.
What is the GO ID for transcription corepressor binding?
The GO ID is GO:0001222.
What is the synonym for GO:0001222?
The synonym is RNA polymerase II transcription corepressor binding.
How can I study transcription corepressor binding with CRISPR?
CRISPR knockout, point-mutation, knock-in and overexpression models can test the requirement for specific binding interfaces.
What is the role of CtBP1/2 in corepressor binding?
CtBP1/2 oligomerization and NADH/NAD+ binding regulate their corepressor function and G9a-mediated repression.
How does TBL1XR1 relate to corepressor binding?
TBL1XR1 is a component of corepressor complexes, and its mutations drive extranodal lymphoma.
What methods are used to measure transcription corepressor binding?
Common methods include RNA-seq, proteomics, ChIP-seq, live-cell imaging and behavioral assays.
Conclusion
GO:0001222 transcription corepressor binding is a central molecular function that enables negative regulation of transcription through protein-protein interactions. Its dysregulation is implicated in cancer, neurological disorders and genome instability. CRISPR-based models and multi-omics methods are essential to dissect the causal roles of corepressor-binding interfaces. EDITGENE provides the tools and services to accelerate this research.
References
- 1. Armache A et al.. 2020. Histone H3.3 phosphorylation amplifies stimulation-induced transcription.. Nature 583(7818):852-857 PMID: 32699416
- 2. Zhang B et al.. 2026. CtBP1/2 oligomerization promotes G9a-Mediated transcriptional repression.. J Biol Chem 302(2):111063 PMID: 41419197
- 3. Venturutti L et al.. 2020. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.. Cell 182(2):297-316.e27 PMID: 32619424
- 4. Gupta K et al.. 2016. Zooming in on Transcription Preinitiation.. J Mol Biol 428(12):2581-2591 PMID: 27067110
- 5. Pandiloski N et al.. 2024. DNA methylation governs the sensitivity of repeats to restriction by the HUSH-MORC2 corepressor.. Nat Commun 15(1):7534 PMID: 39214989
- 6. Guo C et al.. 2009. Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.. Mol Cell Biol 29(10):2644-57 PMID: 19289505
- 7. Erlandsen H et al.. 2022. NADH/NAD(+) binding and linked tetrameric assembly of the oncogenic transcription factors CtBP1 and CtBP2.. FEBS Lett 596(4):479-490 PMID: 34997967
- 8. Schoch H et al.. 2014. Transcriptional co-repressors and memory storage.. Neuropharmacology 80:53-60 PMID: 24440532
